National Collaborative to Improve Care of Children With Complex Congenital Heart Disease Read more about National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) Read more about A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children Read more about A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome Read more about Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants Read more about Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants
Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial Read more about Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant Read more about Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control Read more about Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Pediatric Patients for Pain Control
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Read more about Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Read more about Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery